{"nct_id":"NCT04578756","title":"Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2021-02-01","start_date_type":"ACTUAL","primary_completion_date":"2025-10","primary_completion_date_type":"ESTIMATED","completion_date":"2025-10","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ABBV"]}